Diabetes and stress-induced hyperglycemia affect an estimated 30% to 45% of all hospitalized patients.
The analysis found that at least 38 minutes of moderate intensity exercise each day was associated with the lower risk, which is a little more than the current recommendations of at least 30 minutes a day, 5 days a week.
The new research shows that adolescents are 9 times more likely to receive a vaccine when providers introduce the topic to parents with a simple statement such as “your child is due for vaccines today,” as it results in a shorter vaccine discussion.
For patients with COVID-19, mitochondria are one of the first lines of defense in fighting the virus.
Although only a proportion of DCIS cases will progress into invasive cancer, the treatments available for DCIS are similar to treatments for invasive breast cancers.
Smoking was associated with not only a greater risk of disease, but also an increased risk of severe COVID-19. 

The FDA has granted an orphan drug designation to the BCMA-targeted trispecific T-cell activating recombinant protein construct as treatment for patients with multiple myeloma.
Liam Townsend, MD, and his co-authors looked at a number of measures of recovery for 153 patients who were followed in an outpatient clinic a median of 75 days after their COVID-19 diagnoses.
Approximately one-third of children with COVID-19 are asymptomatic, according to a study conducted by researchers at the University of Alberta.
As patients with HIV are living longer, they are also being diagnosed with chronic conditions that have become increasingly common in recent decades, putting them at higher risk of COVID-19 hospitalization and death.
Study finds the COVID-19 pandemic has drastically improved the quality and convenience of virtual cancer care. 
Researchers from the University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease.
Pharmacists and pharmacy managers would be well served by learning some finer points of negotiation.
The FDA will review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease.
There is particular interest in monoclonal antibody agents to determine whether their immune suppressive effects can reduce the immediate and long-term impact of COVID-19.